Immunogenicity of Peanut Proteins Containing Poly(Anhydride) Nanoparticles
Open Access
- 4 June 2014
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 21 (8) , 1106-1112
Abstract
In the last decade, peanut allergy has increased substantially. Significant differences in the prevalence among different countries are attributed to the type of thermal processing. In spite of the high prevalence and the severe reaction induced by peanuts, there is no immunotherapy available. The aim of this work was to evaluate the potential application of poly(anhydride) nanoparticles (NPs) as immunoadjuvants for peanut oral immunotherapy. NPs loaded with raw or roasted peanut proteins were prepared by a solvent displacement method and dried by either lyophilization or spray-drying. After physicochemical characterization, their adjuvant capacity was evaluated after oral immunization of C57BL/6 mice. All nanoparticle formulations induced a balanced TH1 and TH2 antibody response, accompanied by low specific IgE induction. In addition, oral immunization with spray-dried NPs loaded with peanut proteins was associated with a significant decrease in splenic TH2 cytokines (interleukin 4 [IL-4], IL-5, and IL-6) and enhancement of both TH1 (gamma interferon [IFN-γ]) and regulatory (IL-10) cytokines. In conclusion, oral immunization with poly(anhydride) NPs, particularly spray-dried formulations, led to a pro-TH1 immune response.Keywords
This publication has 44 references indexed in Scilit:
- Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticlesJournal of Controlled Release, 2012
- A European perspective on immunotherapy for food allergiesJournal of Allergy and Clinical Immunology, 2012
- Nanoparticulate Adjuvants and Delivery Systems for Allergen ImmunotherapyJournal of Biomedicine and Biotechnology, 2012
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic responseJournal of Allergy and Clinical Immunology, 2011
- Programming the magnitude and persistence of antibody responses with innate immunityNature, 2011
- Peanut allergy and anaphylaxisCurrent Opinion in Immunology, 2010
- Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor ExploitationClinical and Vaccine Immunology, 2010
- Peanut oral immunotherapy is not ready for clinical useJournal of Allergy and Clinical Immunology, 2010
- A EuroPrevall review of factors affecting incidence of peanut allergy: priorities for research and policyAllergy, 2008
- Bioadhesive Properties of Gantrez NanoparticlesMolecules, 2005